Cargando…

The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism

A 43-year-old African American with end-stage renal disease (ESRD) associated with membranous nephropathy and a previously failed renal transplant had received cinacalcet to treat his secondary hyperparathyroidism. Serum calcium and phosphorus levels remained within normal limits, and serum parathyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalpey, Zain, Nehs, Matthew A., ElBardissi, Andrew W., Semel, Marcus, Tullius, Stefan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421548/
https://www.ncbi.nlm.nih.gov/pubmed/25949409
http://dx.doi.org/10.1093/ndtplus/sfp120
_version_ 1782369894461865984
author Khalpey, Zain
Nehs, Matthew A.
ElBardissi, Andrew W.
Semel, Marcus
Tullius, Stefan G.
author_facet Khalpey, Zain
Nehs, Matthew A.
ElBardissi, Andrew W.
Semel, Marcus
Tullius, Stefan G.
author_sort Khalpey, Zain
collection PubMed
description A 43-year-old African American with end-stage renal disease (ESRD) associated with membranous nephropathy and a previously failed renal transplant had received cinacalcet to treat his secondary hyperparathyroidism. Serum calcium and phosphorus levels remained within normal limits, and serum parathyroid levels had dropped significantly following treatment initiation. However, within 7 months, the patient experienced extensive necrotic bilateral medial thigh ulcers. These were biopsied and found to be a result of calciphylaxis. The patient ultimately required an urgent subtotal parathyroidectomy and recovered well with completely healed ulcers.
format Online
Article
Text
id pubmed-4421548
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44215482015-05-06 The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism Khalpey, Zain Nehs, Matthew A. ElBardissi, Andrew W. Semel, Marcus Tullius, Stefan G. NDT Plus Case Report A 43-year-old African American with end-stage renal disease (ESRD) associated with membranous nephropathy and a previously failed renal transplant had received cinacalcet to treat his secondary hyperparathyroidism. Serum calcium and phosphorus levels remained within normal limits, and serum parathyroid levels had dropped significantly following treatment initiation. However, within 7 months, the patient experienced extensive necrotic bilateral medial thigh ulcers. These were biopsied and found to be a result of calciphylaxis. The patient ultimately required an urgent subtotal parathyroidectomy and recovered well with completely healed ulcers. Oxford University Press 2010-02 2009-09-08 /pmc/articles/PMC4421548/ /pubmed/25949409 http://dx.doi.org/10.1093/ndtplus/sfp120 Text en © The Author 2009. Published by Oxford University Press [on behalf of ERA-EDTA]. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Khalpey, Zain
Nehs, Matthew A.
ElBardissi, Andrew W.
Semel, Marcus
Tullius, Stefan G.
The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
title The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
title_full The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
title_fullStr The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
title_full_unstemmed The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
title_short The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
title_sort importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421548/
https://www.ncbi.nlm.nih.gov/pubmed/25949409
http://dx.doi.org/10.1093/ndtplus/sfp120
work_keys_str_mv AT khalpeyzain theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT nehsmatthewa theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT elbardissiandreww theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT semelmarcus theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT tulliusstefang theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT khalpeyzain importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT nehsmatthewa importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT elbardissiandreww importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT semelmarcus importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism
AT tulliusstefang importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism